{
    "title": "Scanning ultrasound removes amyloid-A and restores memory in an Alzheimer's disease mouse model",
    "inventor_name": "Gerhard Leinenga and JA1/4rgen GAPtz",
    "publication_year": 2015,
    "device_name": "Scanning Ultrasound (SUS) system",
    "goal": "Remove amyloid plaques and restore memory function in Alzheimer's disease",
    "problem_addressed": "Amyloid-beta accumulation in Alzheimer's disease leading to cognitive decline",
    "concept_summary": "Repeated scanning ultrasound (SUS) treatments combined with intravenously injected microbubbles transiently open the blood-brain barrier, activate resident microglia, and promote lysosomal degradation of amyloid-beta plaques, resulting in reduced plaque burden and improved memory performance in mouse models of Alzheimer's disease.",
    "detailed_description": null,
    "category": "Acoustics",
    "principles": [
        "Acoustic cavitation",
        "Blood-brain barrier disruption by microbubble oscillation",
        "Microglia activation and lysosomal clearance",
        "Focused ultrasound scanning"
    ],
    "scientific_domains": [
        "Neurology",
        "Neuroscience",
        "Biomedical Engineering",
        "Acoustics"
    ],
    "mechanisms_of_action": [
        "Ultrasound induces microbubble oscillation causing mechanical stress on vascular walls",
        "Transient opening of tight junctions in the BBB allows entry of blood-borne factors",
        "Activated microglia internalize amyloid-beta into lysosomes for degradation",
        "Repeated treatments prevent age-related dendritic loss"
    ],
    "materials": [
        "DSPC (1,2-distearoyl-sn-glycero-3-phosphocholine)",
        "DSPE-PEG2000 (1,2-distearoyl-sn-glycero-3-phosphoethanolamine-N-[methoxy(polyethylene glycol)-2000])",
        "Octafluoropropane gas",
        "Phosphate-buffered saline (PBS)",
        "Glycerol"
    ],
    "energy_sources": [
        "Acoustic energy (ultrasound)",
        "Electrical power for ultrasound transducer"
    ],
    "inputs": [
        "Ultrasound waves (1 MHz, 0.7 MPa, 10 % duty cycle)",
        "Microbubbles (phospholipid-shelled, octafluoropropane core)",
        "Target brain region"
    ],
    "outputs": [
        "Reduced amyloid plaque burden",
        "Improved performance on Y-maze, novel object recognition, and active place avoidance tasks",
        "No overt neuronal damage or change in excitability",
        "Preservation of dendritic length and complexity"
    ],
    "claimed_performance": "Cleared amyloid plaques in 75 % of SUS-treated mice; restored memory performance in three behavioral tests; prevented age-related dendritic loss in wild-type mice.",
    "experimental_evidence": "Mouse studies (APP23 transgenic Alzheimer's model and wild-type mice) showing plaque reduction, microglial internalization of amyloid, unchanged neuronal excitability, and preserved dendritic morphology after repeated SUS treatments; data published in Science Translational Medicine (2015) and PLOS ONE (2016).",
    "replication_status": "Only reported by the original investigators; no independent replication noted in the article.",
    "keywords": [
        "ultrasound",
        "microbubbles",
        "blood-brain barrier",
        "amyloid-beta",
        "Alzheimer's disease",
        "microglia",
        "non-invasive therapy"
    ],
    "related_technologies": [
        "Focused ultrasound for BBB opening",
        "Microbubble contrast agents",
        "Neuro-imaging and neuromodulation"
    ],
    "controversy_level": "low",
    "confidence_score": 0.9,
    "practicability_score": 0.6,
    "fringe_score": 0.2,
    "evidence_strength": 0.7,
    "risk_score": 0.2,
    "trl_estimate": 4,
    "source_urls": [
        "http://stm.sciencemag.org/content/7/278/278ra33",
        "http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0164278",
        "http://www.abc.net.au/radio/programitem/peOWD0e2P3?play=true",
        "https://qbi.uq.edu.au/interviews/gerhard-leinenga-using-ultrasound-treat-dementia",
        "WO2015192189"
    ],
    "organizations": [
        "University of Queensland",
        "Clem Jones Centre for Ageing Dementia Research"
    ],
    "applications": [
        "Therapeutic treatment of Alzheimer's disease",
        "Neurodegenerative disease therapy",
        "Cognitive function enhancement"
    ],
    "limitations": [
        "Efficacy demonstrated only in mouse models",
        "Requires intravenous microbubble injection",
        "Human safety and dosing parameters not yet established",
        "Potential off-target effects of BBB opening"
    ],
    "open_questions": [
        "What are the optimal ultrasound parameters for safe and effective BBB opening in humans?",
        "Can the approach be scaled to treat the entire human brain uniformly?",
        "What are the long-term effects of repeated BBB disruption?",
        "Will the therapy be effective across different stages and subtypes of Alzheimer's disease?"
    ],
    "red_flags": [
        "Reliance on pre-clinical animal data without human trials",
        "Potential regulatory hurdles for BBB-disrupting devices",
        "Risk of unintended delivery of peripheral substances into the brain"
    ],
    "evidence_quotes": [
        "Scanning ultrasound (SUS) treatments removed amyloid-A and restored memory in an Alzheimer's disease mouse model.",
        "Cleared plaques were observed in 75 % of SUS-treated mice.",
        "No changes in neuronal excitability were observed in SUS-treated neurons compared to sham-treated neurons.",
        "Multiple SUS treatments prevented age-related loss of dendritic length and complexity in wild-type mice.",
        "Ultrasound was combined with microbubbles to disrupt the blood-brain barrier, which is achieved by mechanical interactions between the microbubbles and the blood vessel wall."
    ]
}